<VariationArchive RecordType="classified" VariationID="4242" VariationName="NM_025136.4(OPA3):c.322_339del (p.Gln108_Glu113del)" VariationType="Deletion" Accession="VCV000004242" Version="4" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-10-01" DateCreated="2013-04-04" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19281" VariationID="4242">
      <GeneList>
        <Gene Symbol="OPA3" FullName="outer mitochondrial membrane lipid metabolism regulator OPA3" GeneID="80207" HGNC_ID="HGNC:8142" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="45527427" stop="45584802" display_start="45527427" display_stop="45584802" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="46031024" stop="46088121" display_start="46031024" display_stop="46088121" Strand="-" />
          </Location>
          <OMIM>606580</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025136.4(OPA3):c.322_339del (p.Gln108_Glu113del)</Name>
      <CanonicalSPDI>NC_000019.10:45553714:CTCCTCCTTGTGGCGCTGCT:CT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="45553715" stop="45553732" display_start="45553715" display_stop="45553732" variantLength="18" positionVCF="45553714" referenceAlleleVCF="CCTCCTCCTTGTGGCGCTG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="46056973" stop="46056990" display_start="46056973" display_stop="46056990" variantLength="18" positionVCF="46056972" referenceAlleleVCF="CCTCCTCCTTGTGGCGCTG" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>320_337del</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.45553717_45553734del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.45553717_45553734del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.46056975_46056992del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.46056975_46056992del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013332.1" sequenceAccession="NG_013332" sequenceVersion="1" change="g.36133_36150del">
            <Expression>NG_013332.1:g.36133_36150del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025136.4" sequenceAccession="NM_025136" sequenceVersion="4" change="c.322_339del" MANESelect="true">
            <Expression>NM_025136.4:c.322_339del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079412.1" sequenceAccession="NP_079412" sequenceVersion="1" change="p.Gln108_Glu113del">
            <Expression>NP_079412.1:p.Gln108_Glu113del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001017989.3" sequenceAccession="NM_001017989" sequenceVersion="3" change="c.143-24276_143-24259del">
            <Expression>NM_001017989.3:c.143-24276_143-24259del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340208" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606580.0004" DB="OMIM" />
        <XRef Type="rs" ID="80356526" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025136.4(OPA3):c.322_339del (p.Gln108_Glu113del) AND 3-Methylglutaconic aciduria type 3" Accession="RCV000004464" Version="5">
        <ClassifiedConditionList TraitSetID="1171">
          <ClassifiedCondition DB="MedGen" ID="C0574084">3-Methylglutaconic aciduria type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2002-07-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2002-07-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301646</ID>
          <ID Source="BookShelf">NBK1473</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="BookShelf">NBK12126933</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12126933</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1171" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="7" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">3-methylglutaconic aciduria type III</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPA3-Related 3-Methylglutaconic Aciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-alpha methylglutaconic aciduria type III</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MGA type III</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPA3, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="258501" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="258501" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic atrophy infantile with chorea and spastic paraplegia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Iraqi Jewish optic atrophy plus</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Costeff optic atrophy syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-Methylglutaconic aciduria type 3</ElementValue>
                <XRef ID="3-Methylglutaconic+Aciduria+Type+III/34" DB="Genetic Alliance" />
                <XRef ID="297232009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OPA3</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MGCA3</ElementValue>
                <XRef Type="MIM" ID="258501" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MGA3</ElementValue>
                <XRef Type="MIM" ID="258501" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5663" />
                <XRef ID="5663" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Costeff syndrome is characterized by optic atrophy and/or choreoathetoid movement disorder with onset before age ten years. Optic atrophy is associated with progressive decrease in visual acuity within the first years of life, sometimes associated with infantile-onset horizontal nystagmus. Most individuals have chorea, often severe enough to restrict ambulation. Some are confined to a wheelchair from an early age. Although most individuals develop spastic paraparesis, mild ataxia, and occasional mild cognitive deficit in their second decade, the course of the disease is relatively stable.</Attribute>
                <XRef ID="NBK1473" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301646</ID>
                <ID Source="BookShelf">NBK1473</ID>
              </Citation>
              <XRef ID="67047" DB="Orphanet" />
              <XRef ID="C0574084" DB="MedGen" />
              <XRef ID="MONDO:0009787" DB="MONDO" />
              <XRef Type="MIM" ID="258501" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24637" SubmissionDate="2020-06-17" DateLastUpdated="2020-06-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606580.0004_3-@METHYLGLUTACONIC ACIDURIA, TYPE III" title="OPA3, 18-BP DEL, NT320_3-@METHYLGLUTACONIC ACIDURIA, TYPE III" />
        <ClinVarAccession Accession="SCV000024637" DateUpdated="2020-06-22" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 14-year-old boy, born of first-cousin Kurdish-Turkish parents, with 3-methylglutaconic aciduria type III (MGCA3; 258501), Kleta et al. (2002) identified a homozygous 18-bp deletion in exon 2 of the OPA3 gene, resulting in the deletion of 6 amino acids between codons 108 and 113. As a child, the boy had ataxic gait and 3-methylglutaconic aciduria. Decreased visual acuity with optic atrophy was diagnosed at age 9 years. At age 13, he was physically active with normal intelligence, but had mild ataxic restlessness.</Attribute>
              <Citation>
                <ID Source="PubMed">12126933</ID>
              </Citation>
              <XRef DB="OMIM" ID="258501" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA3" />
          </GeneList>
          <Name>OPA3, 18-BP DEL, NT320</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">18-BP DEL, NT320</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606580.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">3-@METHYLGLUTACONIC ACIDURIA, TYPE III</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="41514" SubmissionDate="2022-07-22" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_025136.2:c.322_339del|MedGen:C0574084" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000041514" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1473</ID>
          </Citation>
          <Citation>
            <ID Source="BookShelf">NBK12126933</ID>
          </Citation>
          <Comment>Found in an individual of Turkish-Kurdish origin with Costeff syndrome</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>320_337del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025136.2:c.322_339del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0574084" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>SUB11843384</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="41514" TraitType="Disease" MappingType="XRef" MappingValue="C0574084" MappingRef="MedGen">
        <MedGen CUI="C0574084" Name="3-Methylglutaconic aciduria type 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

